Skip to content
Business Company News, Medical Health Aged Care

The Hon Gabrielle Upton joins the Florey Board

- 2 mins read

The Florey is pleased to announce the appointment of the Hon Gabrielle Upton to its Board of Directors. 

Ms Upton has had a distinguished career as a lawyer, banker, government minister and university Deputy Chancellor. 

She was New South Wales’ first female Attorney General, is a Board Member of Netball Australia, and serves as an Advisory Board Member of the Australian Research Council Centre of Excellence of Quantum Biotechnology.  

The Florey’s Board Chair, Mr Martin Adams, welcomed Ms Upton to the Board.   

“Gabrielle is a leader who brings a wealth of experience to The Florey. She has extensive knowledge of medical research, neuroscience and higher education, having previously served on the board of Neuroscience Research Australia (NeuRA) and as Deputy Chancellor of the University of New South Wales,” Mr Adams said. 

“The Florey is building momentum, working at the frontier of neuroscience and mental health. Our work is transforming lives and communities here in Australia and around the world. It’s an exciting time for Gabrielle to be joining the Florey, and we are delighted to have her as a member of the Board. 

Ms Upton said she was excited to join The Florey board.  

“The Florey has a distinguished history and bright future finding the causes and cures for diseases affecting the brain – the least understood part of our body. I particularly look forward to supporting its work to improve the lives of people living with brain and mental health conditions,” she said.

 


About us:

The Florey is Australia’s leading brain research institute with a focus on improving the lives of people with neurological and psychiatric conditions. The Florey’s research missions are centred around dementiaepilepsymental health and developing ways to protect and repair the brain. These missions are strengthened by The Florey’s expertise in neurotherapeutics, neuroimaging, synaptic biology and systems neuroscience. With 600 researchers, The Florey is the largest research centre of its kind in the southern hemisphere.

Find out more about us on our website: www.florey.edu.au


Contact details:

Kathryn Powley, Media and Communications Manager

[email protected] | 0456 666 271

Media

More from this category

  • Medical Health Aged Care
  • 29/04/2025
  • 00:10
Olon SpA

Olon Group Strengthens Its Leadership in Bioproduction with Two Strategic Appointments in France

MILAN, April 28, 2025 (GLOBE NEWSWIRE) -- Olon Group, a leading global pharmaceutical CDMO, announces the appointment of Jérôme Bédier as CEO of its French entities and Andrea Conforto as M&S VP CDMO of Olon Biotech, the division dedicated to CDMO services for biologics. These appointments reinforce Olon's strategy to expand its capabilities in Antibody-Drug Conjugates (ADCs), Highly Potent Active Pharmaceutical Ingredients (HPAPIs), and microbial bioproduction.An Integrated Vision for ADCs, HPAPIs, and Microbial BioproductionWith this new leadership structure, Olon Group is accelerating the development of its fully integrated ADC offering, covering the entire value chain from Cell Line Development (CLD) to…

  • Medical Health Aged Care
  • 28/04/2025
  • 22:41
Mainstay Medical Holdings plc

Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Anthem Blue Cross/Blue Shield

DUBLIN--BUSINESS WIRE-- Mainstay Medical Holdings plc today announced that Anthem Blue Cross and Blue Shield (“Anthem”) has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for the treatment of intractable chronic low back pain. ReActiv8 is the only therapy considered medically necessary by the policy when the conditions for coverage are met. The coverage went into effect on April 16, 2025, and expands access to the procedure, when clinically appropriate, to Anthem’s policyholders. “We have been on a 17-year mission to prove the value of ReActiv8 through careful and thorough research,”said Jason Hannon, CEO of Mainstay Medical.“We have…

  • Medical Health Aged Care
  • 28/04/2025
  • 21:26
Eurosets

Life-saving Technologies at EuroELSO 2025: Eurosets Presents Landing Breathe and Xtreme Rescue

MILAN–BUSINESS WIRE– Eurosets, a cutting-edge Italian company specializing in the design of life-saving medical devices, unveils two crucial innovations at the EuroELSO 2025 congress:…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.